An open label single arm prospective clinical study in the management of Pakshaghata (CVA due to infarct) with Maharasnadi Kashaya and Shunti Churna
Abstract
Pakshaghata is one among 80 Vata Namathmaja Vyadhi. In Pakshaghata vitiated Vata resides in one half of body and causes Vishoshana of Sira and Snayu leading to loosening of joints results into manifestation of symptoms like Cheshta Nivrutti, Ruja and Vakstambha. Pakshaghata can be correlated to stroke or CVA. The study aims to evaluate the combined effectiveness of Maharasnadi Kashaya with Shunti Churna as Anupana in management of Pakshaghata (CVA due to infarct). The open label prospective clinical study was conducted among the 32 patients of Pakshaghata by convenient sampling method at a tertiary Hospital Sri Dharmasthala Manjunatheshwara College of Ayurveda & Hospital, Hassan, Karnataka from December 2018 to December 2019. The effectiveness of the drug showed improvement in primary outcome measures such as Cheshta Nivrutti, Vakstambha and Ruk in subjects of Pakshaghata with p value < 0.05. In this study, maximum improvement was found in “Ruk” followed by “Cheshta Nivrutti” and then “Vak Stambha”. Hence this drug is more effective in “Saruja Pakshaghata” hence; it showed improvement in the NIH stroke scale parameters with p value < 0.05. The combined effectiveness of Maharasnadi Kashaya with Shunti Churna as Anupana in management of Pakshaghata (CVA due to Infarct) is proved.
Downloads
References
Kuldeep, Prashanth AS, Chavan SG. Clinical evaluation of Nasya Karma and Vatagajankusha Rasa effect in the management of Pakshaghata. J Ayurveda Integr Med Sci. 2019;4(04).
MG R, Acharya GS. Clinical study on the efficacy of Rasayana in the management of Margavaranajanya Pakshaghata (Ischaemic Stroke)J of Ayurveda and Hol Med (JAHM).2014;2(9):16-21.
Gopan Y, Muttappa T, Vasantha B, Kiran K. An open label single arm prospective clinical study on Vatagajankusha Rasa with Pippali Churna and Manjishta Kwatha as Anupana in Pakshaghata (CVA due to Infarct). J Ayurveda Integr Med Sci 2019;6:19- 25.
Coupland AP, Thapar A, Qureshi MI, Jenkins H, Davies AH. The definition of stroke. J R Soc Med. 2017;110(1):9–12.
World Stroke Organisation (Switzerland) WSO annual report; 2018. http://s1.q4cdn.com/714383399/files/oar/2018/Annu alReport2018/assets/pdf/FedEx-Annual-Report- 2018.pdf
World Stroke Organization (Switzerland), WSO Global stroke fact sheet;2018.
Dr. Bramhanada Tripathi editor, (1st edition). Commentry Dipika on Sarangadhara Samhita of Sarangadhara, Madhyamkhanda; Chapter kwath kalpana: Chapter no. 2, Verse No. 3,5 , Varanasi: Chaukhamba Surbharti Prakashan, 2013; pg 90
Stroke. Centre for disease control. 2020 [ cited on 25 February 2020]. available from: https://www.cdc.gov/stroke/types_of_stroke.htm
Jyotir Mitra, Vaghata kruta Astanga Sangraha with Sasilekha commentary. Prof (editor). Sutrasthana, Bheshaja vicharaniya adhyaya (chap 23), Verse 27; Chowkhamba Sanskrit Series Office, Varanasi. 2012; pg 182.
Patil U.Standarization and quality evaluation of selected single drug formulations (Choornas) from an Ayurvedic Pharmacy. Int.J.Res.Ayurveda Pharm. 2014;5(4):457-460 http://dx.doi.org/10.7897/2277- 4343.05494
Ashtang hrudaya, sutrasthana 12 chapt, shreekanth murthy shloka no. 06-07,pg no 167.
Acharya YT . Charak Samhita with Ayurveda Dipika commentary of Chakrapani Datta. Chikitsa Sthan 28/100. Reprinted. Varanasi(India): Chaukhambha Orientalia; 2014
Mundugaru R, Sivanesan S, Popa-Wagner A, Udaykumar P, Kirubagaran R, KP G, et al. Pluchea lanceolata protects hippocampal neurons from endothelin-1 induced ischemic injuryto ameliorate cognitive deficits. J Chem Neuroanat [Internet]. 2018;94 (September):75–85. Available from: https://doi.org/10.1016/j.jchemneu.2018.09.002
To ameliorate cognitive deficits. J Chem Neuroanat [Internet]. 2018;94(September):75–85. Available from: https://doi.org/10.1016/j.jchemneu.2018.09.002
Zhao, JJ., Song, JQ., Pan, SY. et al. Neurochem Res (2016) 41: 1939.
Lucetti DL, Lucetti ECP, Bandeira MAM, Veras HNH, Silva AH, Leal LKAM, et al. Anti-inflammatory effects and possible mechanism of action of lupeol acetate isolated from Himatanthus drasticus (Mart.) Plumel. J Inflamm [Internet]. 2010;7(1):60. Available from: http://www.journal-inflammation.com/content/7/1/60
Journal of Ayurveda and Integrated Medical Sciences (JAIMS) retains the copyright of the contents of this journal but grant the readers the right to use the contents with terms and conditions under a creative common attribution licenses 4 of Attribution, Share Alike and Non-commercial type (CC BY-NC-SA) that allows copy, distribute, display, and perform the work and make derivative works based on it only for non-commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
